Now Part Of Catalent Biologics

The Vaccine Manufacturing and Innovation Centre (VMIC) has been established to promote, develop and accelerate the growth of the UK vaccine sector for the benefit of the UK and beyond. Through collaboration with academic, research and industry teams, start-ups and SMEs, to multinationals, VMIC will accelerate vaccines from discovery to licensed product. VMIC provides expertise in process development and manufacturing in the form of expert staff and a state-of-the-art manufacturing facility. VMIC will bridge the gap between research and expertise in development and manufacturing so that new vaccine products can enter clinical development, which is a value driver in terms of attracting funding for further development, partnering with the pharmaceutical industry for development to launch, and contract manufacturing. The Centre will also serve as the national response capability for the UK government in order to produce vaccines against future pandemics/ emerging infectious diseases, and deliberate/accidental release of biological agents.